Publications

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

AuthID
P-00X-DRW

Author(s)

Bedke, J

Albiges, L

Capitanio, U

Giles, RH

Hora, M

Ljungberg, B

Marconi, L

Klatte, T

Volpe, A

Abu Ghanem, Y

Dabestani, S

Fernandez Pello, S

Hofmann, F

Kuusk, T

Tahbaz, R

Powles, T

Bex, A

Document Type

Article

Year published

2023

Published

in EUROPEAN UROLOGY, ISSN: 0302-2838

Volume: 83, Issue: 1, Pages: 10-+ (3)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.eururo.2022.10.010

Pubmed: 36511268

Scopus: 2-s2.0-85140624777

Wos: WOS:000989352400004

Source Identifiers

ISSN: 0302-2838

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

Useful Links

Get Help

Federated Authentication (Click on the image)

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

Useful Links

Get Help